Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#11 / 75 Total
HSDT - Helius Medical Technologies Inc - Stock Price Chart
TickerHSDT [NASD]
CompanyHelius Medical Technologies Inc
CountryUSA
IndustryMedical Devices
Market Cap2.08MEPS (ttm)-12.96
P/E-EPS this Y62.43%
Forward P/E-EPS next Y44.97%
PEG-EPS past 5Y63.34%
P/S3.11EPS next 5Y-
P/B0.31EPS Q/Q30.36%
Dividend-Sales Q/Q21.62%
Insider Own1.79%Inst Own0.89%
Insider Trans0.00%Inst Trans-
Short Float1.51%EarningsMay 13/a
Analyst Recom1.00Target Price4.00
Avg Volume395.47K52W Range0.77 - 13.43
Helius Medical Technologies, Inc. is a neurotech company in the medical device industry that focuses on neurological wellness. The firm develops, licenses and acquires non-invasive platform technologies that amplify the brain's ability to heal itself and reduce symptoms of neurological disease or trauma. It engages in the development of the investigational portable neuromodulation stimulator, that delivers neurostimulation via the tongue which has been shown in clinical studies to enhance the effectiveness of physical exercises in people with neurological symptoms from disease or trauma such as mild-to-moderate traumatic brain injury. The company was founded in 2014 and is headquartered in Newtown, PA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ANDREEFF DANEPresident and CEODec 14 '23Buy8.105,00040,47516,512Dec 15 07:00 AM
ANDREEFF DANEPresident and CEODec 01 '23Buy6.452,00612,93513,685Dec 04 08:30 AM
ANDREEFF DANEPresident and CEONov 30 '23Buy6.372,00012,74112,551Dec 04 08:30 AM
ANDREEFF DANEPresident and CEOAug 30 '23Buy7.645,00038,21211,420Aug 30 08:42 PM
ANDREEFF DANEPresident and CEOAug 28 '23Buy6.375,07832,3398,774Aug 30 08:42 PM
PSIG - PS International Group Ltd. - Stock Price Chart
TickerPSIG [NASD]
CompanyPS International Group Ltd.
CountryHong Kong
IndustryIntegrated Freight & Logistics
Market Cap5.13MEPS (ttm)-0.31
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B0.88EPS Q/Q-4508.33%
Dividend-Sales Q/Q-
Insider Own76.39%Inst Own22.34%
Insider Trans0.00%Inst Trans-
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume193.44K52W Range1.55 - 12.25
PS International Group Ltd. engages in providing logistics and supply chain solutions. The company was founded on September 12, 2023 and is headquartered in Hong Kong.
GDTC - CytoMed Therapeutics Ltd - Stock Price Chart
TickerGDTC [NASD]
CompanyCytoMed Therapeutics Ltd
CountrySingapore
IndustryBiotechnology
Market Cap20.89MEPS (ttm)-0.27
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B2.45EPS Q/Q9.49%
Dividend-Sales Q/Q-
Insider Own59.01%Inst Own0.00%
Insider Trans0.00%Inst Trans-
Short Float0.82%EarningsMay 29
Analyst Recom1.00Target Price5.00
Avg Volume71.92K52W Range1.88 - 5.50
Jul-17-24 07:00AM Presenting on the Emerging Growth Conference 73 Day 2 on July 18 Register Now (GlobeNewswire) +14.29%
07:00AM CytoMed Therapeutics Acquires Cord Blood Banking Licence and Assets to Entrench Its Strategy in Allogeneic, Off-the-shelf Donor-derived Gamma Delta (?d) T Cells Technology for Solid and Liquid Cancers (GlobeNewswire)
07:00AM CytoMed Therapeutics Acquires Cord Blood Banking Licence and Assets to Entrench Its Strategy in Allogeneic, Off-the-shelf Donor-derived Gamma Delta ( ) T Cells Technology for Solid and Liquid Cancers (GlobeNewswire)
Jul-16-24 07:00AM Presenting on the Emerging Growth Conference 73 Day 1 on July 17 Register Now (GlobeNewswire)
Mar-20-24 08:30AM CytoMed Diversifies into Regenerative Medicine after Research Collaboration with Singapore's Sengkang General Hospital to Test Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Regeneration (ACCESSWIRE) -5.60%
Mar-18-24 06:00AM CytoMed Therapeutics to Launch Complimentary Cell Banking for Qualified Shareholders for Future Precision Therapies (GlobeNewswire) +5.63%
Mar-04-24 05:00AM CytoMed Therapeutics Limited Announces Research Collaboration with Singapore Sengkang General Hospital to Advance Injectable Umbilical Cord-Derived Mesenchymal Stem Cells for Cartilage Diseases and Repair (GlobeNewswire)
Jan-29-24 07:00AM Malaysian Patent Granted for CytoMed Therapeutics' Licensed Allogeneic CAR-Gamma Delta T Cell Technology (GlobeNewswire)
Dec-05-23 07:30AM CytoMed Therapeutics Signs HOA and MOU to Advance Research on Allogeneic Gamma Delta T Cell Technology (PR Newswire)
Nov-17-23 09:21AM CytoMed Therapeutics Reports First Half 2023 Financial Report and Provides Corporate Update (PR Newswire) -8.60%
CytoMed Therapeutics Ltd. is a biopharmaceutical company, which engages in the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy, and undertaking the research and development of immune cell and stem cell-based therapy. It operates through the Malaysia and Singapore geographical segments. The company was founded by Chee Kong Choo on March 9, 2018 and is headquartered in Singapore.
CCTG - CCSC Technology International Holdings Ltd - Stock Price Chart
TickerCCTG [NASD]
CompanyCCSC Technology International Holdings Ltd
CountryHong Kong
IndustryElectrical Equipment & Parts
Market Cap18.56MEPS (ttm)-0.01
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S9.87EPS next 5Y-
P/B12.16EPS Q/Q-159.43%
Dividend-Sales Q/Q-53.44%
Insider Own82.42%Inst Own0.00%
Insider Trans0.00%Inst Trans-
Short Float1.81%Earnings-
Analyst Recom-Target Price-
Avg Volume64.76K52W Range1.75 - 30.00
CCSC Technology International Holdings Ltd. operates as a holding company with interests in the designing, manufacturing and sale of interconnect products. Its products include connectors, cables and wire harnesses. The company was founded by Chi Sing Chiu on October 19, 2021 and is headquartered in Hong Kong.
ABVE - Above Food Ingredients Inc. - Stock Price Chart
TickerABVE [NASD]
CompanyAbove Food Ingredients Inc.
CountryCanada
IndustryPackaged Foods
Market Cap11.68MEPS (ttm)-0.02
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B0.55EPS Q/Q96.65%
Dividend-Sales Q/Q-
Insider Own36.29%Inst Own18.13%
Insider Trans0.00%Inst Trans5.14%
Short Float2.86%Earnings-
Analyst Recom-Target Price-
Avg Volume103.28K52W Range1.55 - 13.50
Above Food Ingredients, Inc. engages in operating its subsidiaries, Bite Acquisition Corp. (Bite) and Above Food Corp. (Above Food). The Bite is a blank check company that affects a merger, stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The Above Food is an ingredient company that provides food products and brands. The company was founded by Lionel Kambeitz on April 18, 2023 and is headquartered in Regina, Canada.
AACI - Armada Acquisition Corp I - Stock Price Chart
TickerAACI [NASD]
CompanyArmada Acquisition Corp I
CountryUSA
IndustryShell Companies
Market Cap68.09MEPS (ttm)-0.20
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B11.14EPS Q/Q-1987.50%
Dividend-Sales Q/Q-
Insider Own79.09%Inst Own16.14%
Insider Trans0.00%Inst Trans23.39%
Short Float0.73%Earnings-
Analyst Recom-Target Price-
Avg Volume30.24K52W Range10.47 - 12.53
Armada Acquisition Corp. I operates as a blank check company. It was formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or other similar business combination with one or more businesses or entities. The company was founded on November 5, 2020 and is headquartered in Philadelphia, PA.
KDLY - Kindly MD Inc. - Stock Price Chart
TickerKDLY [NASD]
CompanyKindly MD Inc.
CountryUSA
IndustryMedical Care Facilities
Market Cap10.69MEPS (ttm)-0.29
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S3.11EPS next 5Y-
P/B-EPS Q/Q-56.77%
Dividend-Sales Q/Q-28.55%
Insider Own67.96%Inst Own-
Insider Trans0.00%Inst Trans-
Short Float0.56%Earnings-
Analyst Recom-Target Price-
Avg Volume86.39K52W Range1.90 - 4.20
Kindly MD, Inc. provides healthcare services. Its services include medication management, behavioral healthcare and alternative treatments. The firm offers evaluation and management, including chronic pain, functional medicine, cognitive behavioral therapy, trauma and addiction therapy, recovery support services, overdose education efforts, peer support, limited urgent care, preventative medicine, travel services, and hormone therapy. The company was founded by Timothy Pickett in December 2019 and is headquartered in Murray, UT.
CRI - Carters Inc - Stock Price Chart
TickerCRI [NYSE]
CompanyCarters Inc
CountryUSA
IndustryApparel Retail
Market Cap2.09BEPS (ttm)6.36
P/E9.00EPS this Y-9.24%
Forward P/E10.19EPS next Y0.04%
PEG-EPS past 5Y0.77%
P/S0.72EPS next 5Y-1.20%
P/B2.49EPS Q/Q9.09%
Dividend5.50%Sales Q/Q-4.94%
Insider Own2.92%Inst Own116.09%
Insider Trans-0.27%Inst Trans-3.15%
Short Float15.21%EarningsJul 26/b
Analyst Recom3.22Target Price61.33
Avg Volume844.16K52W Range59.06 - 88.03
Carter's, Inc. engages in the business of brand marketing of young children's apparel. It operates through the following segments: the United States (US) Retail, US Wholesale, and International. The US Retail segment includes selling products through retail stores and ecommerce websites. The US Wholesale segment focuses on wholesale partners. The International segment is involved in selling in retail stores and ecommerce websites in Canada and Mexico, and to international wholesale customers and licensees. The company was founded by William Carter in 1865 and is headquartered in Atlanta, GA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Jenkins JeffEVP Global MarketingMar 13 '24Sale86.001,06091,16035,173Mar 13 04:27 PM
Hipp MarkDirectorMar 06 '24Sale81.741,875153,26110,216Mar 22 08:46 AM
CASEY MICHAEL DENNISChairman and CEODec 14 '23Option Exercise68.4930,0002,054,700479,870Dec 15 04:16 PM
CASEY MICHAEL DENNISChairman and CEODec 14 '23Sale75.0089,1396,685,425390,731Dec 15 04:16 PM
D'Emilio JulieEVP, SalesDec 08 '23Option Exercise68.493,400232,86646,183Dec 08 04:31 PM
MXL - MaxLinear Inc - Stock Price Chart
TickerMXL [NASD, RUT]
CompanyMaxLinear Inc
CountryUSA
IndustrySemiconductors
Market Cap1.06BEPS (ttm)-2.31
P/E-EPS this Y-176.36%
Forward P/E27.77EPS next Y154.76%
PEG-EPS past 5Y-18.83%
P/S2.37EPS next 5Y14.14%
P/B1.74EPS Q/Q-769.50%
Dividend-Sales Q/Q-49.99%
Insider Own8.31%Inst Own85.06%
Insider Trans-0.17%Inst Trans-0.37%
Short Float4.95%EarningsJul 24/a
Analyst Recom2.09Target Price22.33
Avg Volume825.71K52W Range13.43 - 35.00
MaxLinear, Inc. engages in the provision of communications systems-on-chip, or SoC, solutions used in broadband, mobile and wireline infrastructure, data center, and industrial and multi-market applications. Its products include cable broadband modems and gateways, wireline connectivity devices, radio frequency transceivers, fiber-optic modules, video set-top boxes and gateways, hybrid analog and digital televisions, direct broadcast satellite outdoor and indoor units, and power management and interface products. The company was founded by Kimihiko Imura, Curtis C. Ling and Kishore V. Seendripu on September 25, 2003 and is headquartered in Carlsbad, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ARTUSI DANIEL ADirectorMay 01 '24Option Exercise0.009,170029,802May 03 04:09 PM
MOYER ALBERT JDirectorMay 01 '24Option Exercise0.009,170069,822May 03 04:08 PM
Tewksbury Ted L IIIDirectorMay 01 '24Option Exercise0.009,170070,726May 03 04:09 PM
Liu Tsu-Jae KingDirectorMar 30 '24Option Exercise0.001,933017,903Apr 02 04:26 PM
Kwong Connie H.Corporate Controller & PAOMar 04 '24Option Exercise0.001,019044,745Mar 06 04:33 PM
ATXI - Avenue Therapeutics Inc - Stock Price Chart
TickerATXI [NASD]
CompanyAvenue Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap2.56MEPS (ttm)-39.72
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y50.07%
P/S-EPS next 5Y-
P/B0.57EPS Q/Q92.40%
Dividend-Sales Q/Q-
Insider Own7.38%Inst Own1.99%
Insider Trans0.00%Inst Trans-
Short Float4.69%EarningsMay 15/b
Analyst Recom1.00Target Price12.00
Avg Volume80.52K52W Range2.79 - 87.00
Avenue Therapeutics, Inc. is a specialty pharmaceutical company, which engages in acquiring, licensing, and commercializing products for use in the intensive care hospital setting. It focuses on the development of intravenous tramadol, a potential alternative that could reduce the use of conventional opioids for patients suffering from acute pain. The company was founded on February 9, 2015 and is headquartered in Bay Harbor Islands, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Davidow Robert L10% OwnerDec 11 '23Sale0.14353,00049,60022,000Dec 13 04:02 PM
Davidow Robert L10% OwnerDec 11 '23Sale0.14264,00036,960681,000Dec 13 04:02 PM
Fortress Biotech, Inc.10% OwnerSep 08 '23Buy0.72418,410301,2551,032,390Sep 12 09:02 AM
ROSENWALD LINDSAY A MDDirectorSep 08 '23Buy0.72348,675251,046354,318Sep 12 09:03 AM
12345678